Key result
Kaempferol intake is linked to lower cardiovascular disease risk and reduced atherosclerosis progression.
Review reveals anti-atherosclerotic effects of the flavonoid kaempferol across preclinical models, indicating its potential for cardiovascular therapy.
Natural products possess pleiotropic cardiovascular protective effects owing to their anti-oxidation, anti-inflammation and anti-thrombotic properties. Kaempferol, (3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one), is a kind of naturally occurring flavonoid existing in many common fruits and vegetables (e.g., onions, broccoli, strawberries and grapes) and particularly in traditional Chinese medicine as exemplified by Ginkgo biloba. Epidemiological, preclinical and clinical studies have revealed an inverse association between the consumption of kaempferol-containing foods and medicines and the risk of developing cardiovascular diseases. Numerous translational studies in experimental animal models and cultured cells have demonstrated a wide range of pharmacological activities of kaempferol. In this article, we reviewed the antioxidant, anti-inflammatory and cardio-protective activities of kaempferol and elucidated the potential molecular basis of the therapeutic capacity of kaempferol by focusing on its anti-atherosclerotic effects. Overall, the review presents the health benefits of kaempferol-containing plants and medicines and reflects on the potential of kaempferol as a possible drug candidate to prevent and treat atherosclerosis, the underlying pathology of most cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted a review in Atherosclerosis and cardiovascular diseases. Kaempferol was evaluated. Kaempferol consumption is inversely associated with cardiovascular disease risk and demonstrates pharmacological activities that may prevent and treat atherosclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: